These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10678324)

  • 1. Propranolol: a treatment for pseudoakathisia.
    Hermesh H; Manor I; Munitz H
    J Nerv Ment Dis; 1994 Apr; 182(4):241-3. PubMed ID: 10678324
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose mianserin in treatment of acute neuroleptic-induced akathisia.
    Poyurovsky M; Fuchs C; Weizman A
    J Clin Psychopharmacol; 1998 Jun; 18(3):253-4. PubMed ID: 9617987
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudoakathisia: a review and two case reports.
    Stubbs JH; Halstead SM
    Compr Psychiatry; 2000; 41(1):70-2. PubMed ID: 10646622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced dystonia.
    Swett C
    Am J Psychiatry; 1975 May; 132(5):532-4. PubMed ID: 1119613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone.
    Seemüller F; Lewitzka U; Bauer M; Meyer S; Musil R; Schennach R; Riedel M; Doucette S; Möller HJ
    Pharmacopsychiatry; 2012 Nov; 45(7):292-6. PubMed ID: 22614116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous benztropine and propranolol challenges in acute neuroleptic-induced akathisia.
    Sachdev P; Loneragan C
    Clin Neuropharmacol; 1993 Aug; 16(4):324-31. PubMed ID: 8104097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akathisia and suicidal ideation in first-episode schizophrenia.
    Seemüller F; Schennach R; Mayr A; Musil R; Jäger M; Maier W; Klingenberg S; Heuser I; Klosterkötter J; Gastpar M; Schmitt A; Schlösser R; Schneider F; Ohmann C; Lewitzka U; Gaebel W; Möller HJ; Riedel M;
    J Clin Psychopharmacol; 2012 Oct; 32(5):694-8. PubMed ID: 22926606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient.
    D'Souza DC; Bennett A; Abi-Dargham A; Krystal JH
    J Clin Psychopharmacol; 1994 Oct; 14(5):361-3. PubMed ID: 7806697
    [No Abstract]   [Full Text] [Related]  

  • 9. Placebo response in refractory tardive akathisia.
    Remington G; Fornazzari L; Sethna R
    Can J Psychiatry; 1993 May; 38(4):248-50. PubMed ID: 8100184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH; Byun HJ
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akathisia in association with nortriptyline therapy.
    Sabaawi M; Richmond DR; Fragala MR
    Am Fam Physician; 1993 Nov; 48(6):1024, 1026. PubMed ID: 8237726
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis.
    Adler LA; Peselow E; Rosenthal M; Angrist B
    Psychopharmacol Bull; 1993; 29(2):283-6. PubMed ID: 8290678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute nocturnal akathisia induced by clozapine.
    Sahoo S; Ameen S
    J Clin Psychopharmacol; 2007 Apr; 27(2):205. PubMed ID: 17414247
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous benztropine and propranolol challenges in tardive akathisia.
    Sachdev P; Loneragan C
    Psychopharmacology (Berl); 1993; 113(1):119-22. PubMed ID: 7862817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akathisia as violence.
    Galynker II; Nazarian D
    J Clin Psychiatry; 1997 Jan; 58(1):31-2. PubMed ID: 9055838
    [No Abstract]   [Full Text] [Related]  

  • 16. Akathisia and exacerbation of psychopathology: a preliminary report.
    Duncan EJ; Adler LA; Stephanides M; Sanfilipo M; Angrist B
    Clin Neuropharmacol; 2000; 23(3):169-73. PubMed ID: 10895402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priority in the pharmacological management of chronic schizophrenia: the quality of life issues.
    Chiu E
    P N G Med J; 1982 Jun; 25(2):116-20. PubMed ID: 6961626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report. Improvement in a patient with severe akathisia achieved by mianserin].
    Westerlund M
    Lakartidningen; 2000 Oct; 97(40):4474. PubMed ID: 11068403
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria.
    Newcomer JW; Miller LS; Faustman WO; Wetzel MW; Vogler GP; Csernansky JG
    Br J Psychiatry; 1994 Jun; 164(6):834-8. PubMed ID: 7952993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol as a primary treatment of neuroleptic-induced akathisia.
    Irwin M; Sullivan G; Van Putten T
    Hillside J Clin Psychiatry; 1988; 10(2):244-50. PubMed ID: 2906317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.